Antibiotic control measures in Dutch secondary care hospitals

Netherlands Journal of Medicine

Volumn 63, Issue 1, 2005, Pages 24-30

  Schouten, J A ^a   Hulscher, M E J L ^a   Natsch, S ^a   Grol, R P T M ^a   van der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG CONTROL; DRUG FORMULARY; EDUCATION PROGRAM; HEALTH EDUCATION; HEALTH SURVEY; HOSPITAL CARE; HOSPITAL INFECTION; HUMAN; INTRANET; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; NETHERLANDS; PHLEBITIS; PRACTICE GUIDELINE; PRESCRIPTION;

ANTI-BACTERIAL AGENTS; DATA COLLECTION; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; GUIDELINES; HOSPITAL BED CAPACITY; HOSPITALS; HOSPITALS, TEACHING; HUMANS; MEDICATION SYSTEMS, HOSPITAL; NETHERLANDS; PHARMACY SERVICE, HOSPITAL;

EID: 13444265170     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Levy SB. Starting life resistance-free. N Engl J Med 1990;323(5):335-7.
2. Kunin CM, Lipton HL, Tupasi T, et al. Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4. Rev Infect Dis 1987;9(suppl 3):S270-85.
3. Cunha BA. Antibiotic side effects. Med Clin North Am 2001;85(1):149-85.
4. Gleckman RA, Borrego F. Adverse reactions to antibiotics. Clues for recognizing, understanding, and avoiding them. Postgrad Med 1997;101(4):97-4, 107.
5. Lelekis M, Gould IM. Sequential antibiotic therapy for cost containment in the hospital setting: why not? J Hosp Infect 2001;48(4):249-57.
6. Milkovich G. Antibiotic usage: pharmacoeconomic impact in a changing healthcare system. Drugs 1996;52(suppl 2):80-2.
7. Janknegt R, Oude LA, Gould IM, van der Meer JW. Antibiotic use in Dutch hospitals 1991-1996. J Antimicrob Chemother 2000;45(2):251-6.
8. Anderson RM. The pandemic of antibiotic resistance. Nat Med 1999;5(2):147-9.
9. Janknegt R, Wijnands WJ, Caprasse M, Brandenburg W, Schuitenmaker MG, Stobberingh E. Antimicrobial drug use in hospitals in the Netherlands, Germany and Belgium. Eur J Clin Microbiol Infect Dis 1993;12(11):832-8.
10. De Neeling AJ, Overbeek BP, Horrevorts AM, Ligtvoet EE, Goettsch WG. Antibiotic use and resistance of Streptococcus pneumoniae in the Netherlands during the period 1994-1999. J Antimicrob Chemother 2001;48(3):441-4.
11. Beunders AJ. Development of antibacterial resistance: the Dutch experience. J Antimicrob Chemother 1994;33(suppl A):17-22.
12. Davey P, Brown E, Hartman G. Interventions to improve antibiotic prescribing practices for hospital inpatients. Protocol for a Cochrane Review. The Cochrane Library, Chichester, UK: John Wiley & Sons Ltd. Ref type: Generic. Issue 4. 1-1-0003.
13. Van Everdingen JJ, Klazinga NS, van den Broek PJ, Steenhoek A, Mouton RP. [Inventory and comparison of guidelines for antibiotic utilization in Dutch hospitals.] Ned Tijdschr Geneeskd 1990;134(33):1604-7.
14. Stobberingh E, Janknegt R, Wijnands G. Antibiotic guidelines and antibiotic utilization in Dutch hospitals. J Antimicrob Chemother 1993;32(1):153-61.
15. Quintiliani R, Nightingale CH, Crowe HM, Cooper BW, Bartlett RC, Gousse G. Strategic antibiotic decision-making at the formulary level. Rev Infect Dis 1991;13(suppl 9):S770-7.
16. Hospital antibiotic control measures in the UK Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 1994;34(1):21-42.
17. Lesar TS, Briceland LL. Survey of antibiotic control policies in university-affiliated teaching institutions. Ann Pharmacother 1996;30(1):31-4.
18. Gyssens IC, Blok WL, van den Broek PJ, Hekster YA, van der Meer JW. Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine. Eur J Clin Microbiol Infect Dis 1997;16(12):904-12.
19. Gezondheidsraad. Herziene richtlijnen ter bestrijding van ziekenhuis-infecties. Den Haag: Staatsuitgeverij, 1977. Ref Type: Generic.
20. Lawton RM, Fridkin SK, Gaynes RP, McGowan JE Jr. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/ Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000;21(4):256-9.
21. Koekebier G., Mokkink H, Klazinga N. Gebruik van richtlijnen door medisch specialisten. Intern rapport. Utrecht/Nijmegen: WOK/CBO, 2001. Ref Type: Generic.
22. Van Kasteren ME, Gyssens IC, van der Meer JW. Vijf jaar SWAB, een inventarisatie vanuit het veld. Ned Tijdschr Med Microbiol 2000;4:116-7.
23. Feely J, Chan R, Cocoman L, Mulpeter K, O'Connor P. Hospital formularies: need for continuous intervention. BMJ 1990;300(6716):28-30.
24. Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998;338(4):232-8.
25. Grol R, Wensing M. Implementatie, effectieve verandering in de patiëntenzorg. 2e druk. Maarssen: Elsevier Gezondheidszorg, 2001.